HU9602220D0 - Substituted 4h-piranes - Google Patents

Substituted 4h-piranes

Info

Publication number
HU9602220D0
HU9602220D0 HU9602220A HUP9602220A HU9602220D0 HU 9602220 D0 HU9602220 D0 HU 9602220D0 HU 9602220 A HU9602220 A HU 9602220A HU P9602220 A HUP9602220 A HU P9602220A HU 9602220 D0 HU9602220 D0 HU 9602220D0
Authority
HU
Hungary
Prior art keywords
alkyl
pyran
diethoxycarbonyl
substd
trimethyl
Prior art date
Application number
HU9602220A
Other languages
English (en)
Inventor
Vry Jean-Marie-Viktor De
Thomas Glaser
Hans-Georg Heine
Bodo Junge
Frank Mauler
Klaus Urbahns
Reilinde Wittka
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of HU9602220D0 publication Critical patent/HU9602220D0/hu
Publication of HUP9602220A2 publication Critical patent/HUP9602220A2/hu
Publication of HUP9602220A3 publication Critical patent/HUP9602220A3/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/32Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06Antianaemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Hospice & Palliative Care (AREA)
  • Reproductive Health (AREA)
  • Emergency Medicine (AREA)
  • Anesthesiology (AREA)
  • Addiction (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pulmonology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
HU9602220A 1995-08-14 1996-08-13 Substituted 4h-piranes and pharmaceutical preparations containing them HUP9602220A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19529858A DE19529858A1 (de) 1995-08-14 1995-08-14 Substituierte 4H-Pyrane

Publications (3)

Publication Number Publication Date
HU9602220D0 true HU9602220D0 (en) 1996-10-28
HUP9602220A2 HUP9602220A2 (en) 1997-05-28
HUP9602220A3 HUP9602220A3 (en) 1998-04-28

Family

ID=7769442

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9602220A HUP9602220A3 (en) 1995-08-14 1996-08-13 Substituted 4h-piranes and pharmaceutical preparations containing them

Country Status (25)

Country Link
US (1) US5760073A (hu)
EP (1) EP0758648B1 (hu)
JP (1) JPH0959271A (hu)
KR (1) KR970010758A (hu)
CN (1) CN1147512A (hu)
AT (1) ATE190611T1 (hu)
AU (1) AU708956B2 (hu)
CA (1) CA2183048A1 (hu)
CZ (1) CZ239496A3 (hu)
DE (2) DE19529858A1 (hu)
DK (1) DK0758648T3 (hu)
EE (1) EE9600114A (hu)
ES (1) ES2145355T3 (hu)
GR (1) GR3033357T3 (hu)
HU (1) HUP9602220A3 (hu)
IL (1) IL119054A (hu)
MX (1) MX9603342A (hu)
NO (1) NO963374L (hu)
NZ (1) NZ299145A (hu)
PL (1) PL315652A1 (hu)
PT (1) PT758648E (hu)
RU (1) RU2164915C2 (hu)
SI (1) SI0758648T1 (hu)
SK (1) SK105596A3 (hu)
ZA (1) ZA966832B (hu)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2329739T3 (es) * 1997-04-07 2009-11-30 Georgetown University Analogos de cocaina.
US6221550B1 (en) 2000-03-31 2001-04-24 Nexpress Solutions Llc 4H-pyran charge control agents for electrostatographic toners and developers
WO2009006580A1 (en) * 2007-07-05 2009-01-08 Cv Therapeutics, Inc. Optionally condensed dihydropyridine, dihydropyrimidine and dihydropyrane derivatives acting as late sodium channel blockers
US20090012103A1 (en) * 2007-07-05 2009-01-08 Matthew Abelman Substituted heterocyclic compounds
JP5120070B2 (ja) * 2008-05-29 2013-01-16 三浦工業株式会社 水処理装置

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3208628A1 (de) * 1982-03-10 1983-09-22 Bayer Ag, 5090 Leverkusen Neue verbindungen, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel

Also Published As

Publication number Publication date
PL315652A1 (en) 1997-02-17
NZ299145A (en) 1998-03-25
RU2164915C2 (ru) 2001-04-10
SK105596A3 (en) 1997-03-05
AU708956B2 (en) 1999-08-19
HUP9602220A3 (en) 1998-04-28
CN1147512A (zh) 1997-04-16
DE59604649D1 (de) 2000-04-20
DK0758648T3 (da) 2000-07-24
US5760073A (en) 1998-06-02
ATE190611T1 (de) 2000-04-15
PT758648E (pt) 2000-08-31
DE19529858A1 (de) 1997-02-20
EP0758648B1 (de) 2000-03-15
AU6193196A (en) 1997-02-20
HUP9602220A2 (en) 1997-05-28
CA2183048A1 (en) 1997-02-15
EE9600114A (et) 1997-02-17
ZA966832B (en) 1997-02-20
NO963374L (no) 1997-02-17
MX9603342A (es) 1997-03-29
CZ239496A3 (en) 1997-03-12
ES2145355T3 (es) 2000-07-01
NO963374D0 (no) 1996-08-13
EP0758648A1 (de) 1997-02-19
SI0758648T1 (en) 2000-06-30
IL119054A (en) 2000-10-31
JPH0959271A (ja) 1997-03-04
IL119054A0 (en) 1996-11-14
GR3033357T3 (en) 2000-09-29
KR970010758A (ko) 1997-03-27

Similar Documents

Publication Publication Date Title
GR3004789T3 (hu)
HU9600914D0 (en) 4-indolylpiperazinyl derivatives
ZA966832B (en) Substituted 4H-pyrans.
ZA9510695B (en) Use of 1 2-bridged 1 4-dihydropyridines as medicaments
PH31390A (en) Cyclohexadiene derivatives.
DE59606077D1 (de) Acyl-substituierte Aminopyrane mit einer modulierende Wirkung auf Kaliumkanäle